Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Study - DaunoDouble - Daunorubicin 60 / Cytarabine 100, AML Induction I+II, under 60 years of age

Protocol-ID: 627 V1.1 (Mini), STUDY-DAUNODOUBLE- DAUN60/CYTA100, AML Ind. I+II under 60 yrs

Indication(s)

  • Acute Myeloid Leukemia; ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 02.04.2021